3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
4
Phase 3
2
Phase 1
2
Phase 1/2
1
Status
Terminated
1
Recruiting
1
Sponsor Class
OTHER
78
INDUSTRY
42
NIH
36
NETWORK
32
OTHER_GOV
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Lymphoid
1
Conditions
Breast Neoplasms
17
Uterine Cervical Neoplasms
11
Stomach Neoplasms
11
Carcinoma, Non-Small-Cell Lung
11
Ovarian Neoplasms
8
Neoplasms
8
Esophageal Neoplasms
8
Carcinoma, Ovarian Epithelial
7
Fallopian Tube Neoplasms
6
Colorectal Neoplasms
5
Recurrence
4
Neoplasm Metastasis
4
Multiple Myeloma
4
Mouth Neoplasms
4
Head and Neck Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Colonic Neoplasms
4
Carcinoma, Hepatocellular
4
Rectal Neoplasms
3
Nasopharyngeal Carcinoma
3
Lymphoma, Non-Hodgkin
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Glioblastoma
3
Urinary Bladder Neoplasms
2
Prostatic Neoplasms
2
Polycystic Ovary Syndrome
2
Peripheral Nervous System Diseases
2
Melanoma
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Interventions
fludarabine
1
Platelet Transfusion
1
Melphalan
1
Cyclophosphamide
1
Clofarabine
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
OTHER_GOV
×
Leukemia
×
Clear all
NCT05477589
2024-12-19
SCRIPT-AML
Vastra Gotaland Region
Phase 3
Recruiting
170 enrolled
NCT01642563
2015-07-28
IPTAS
Centro Nazionale Sangue
Phase 3
Terminated
456 enrolled